Heather Bresch

Type: Person

Name: Heather Bresch

First reported Jun 12 2013 - Updated Jun 12 2013 - 1 reports

5 Leading Women in Health Care

Watch stocks you care aboutThe single, easiest way to keep track of all the stocks that matter...Your own personalized stock watchlist!It's a 100% FREE Motley Fool service...Does the house of health care have a glass ceiling? For women looking to advance ... [Published Motley Fool Discussion Boards - Jun 12 2013]

Entities: Health Care, Gail Boudreaux, Heather Bresch, UnitedHealth Group Inc

First reported Jun 04 2013 - Updated Jun 04 2013 - 1 reports

Mylan receives favorable ruling for COPD drug patent litigation

Mylan Inc., a generic and specialty pharmaceutical company, has received favorable ruling from Court of Appeals for the Federal Circuit and has reversed the District Court's decision invalidating five of Mylan's patents related to Perforomist. The Court's ... [Published Individual.com - Jun 04 2013]

Entities: Mylan Incorporated, Chronic Obstructive Pulmonary Disease, Patent Litigation

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Mylan Incorporated

Mylan: Brand/Generic Distinction Disintegration Is Necessary

Consolidation in the generic industry is good and necessary, Mylan CEO Heather Bresch said during a recent investor presentation. Mylan is well-positioned in the changing market, she said, thanks to business development such as its biosimilars agreements ... [Published The Rose Sheet - May 22 2013]

Entities: Mylan Incorporated, Heather Bresch, Biocon

First reported May 22 2013 - Updated May 22 2013 - 2 reports

West Virginia University

Judge steps out of degree lawsuit

MORGANTOWN, W.Va. -- U.S. District Judge Irene Keeley has disqualified herself from hearing a lawsuit filed over a 6-year-old degree scandal at West Virginia University, citing a federal statute that requires judges to step aside if their impartiality ... [Published Charleston Gazette - May 22 2013]

Entities: West Virginia University, Heather Bresch, Lawsuit

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Keeley Recuses Herself from Heather Bresch Degree Lawsuit

Keely's order cites a federal statute requiring judges to step aside if their impartiality could reasonably be questioned. ... [Published WSAZ - May 22 2013]

Entities: Heather Bresch, Lawsuit, judges

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Federal Appellate Court rules in favor of Mylan

Mylan previously announced a settlement agreement with Sunovion resolving the litigation relating to Sunovionâs BrovanaÂ® product, depending upon the outcome of the Federal Circuit appeal. Mylan Inc announced that the Court of Appeals for the Federal ... [Published India Infoline - May 22 2013]

Entities: Mylan Incorporated, Appellate Court, Chronic Obstructive Pulmonary Disease, Federal

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Mylan Says Appellate Court's Favorable Ruling Validates Perforomist

Global pharmaceutical company Mylan, Inc. (MYL: Quote) Tuesday said the Court of Appeals for the Federal Circuit has ruled in favor of Mylan Specialty L.P., f/k/a Dey Pharma, L.P. and has reversed the District Court's decision invalidating five of Mylan's ... [Published RTTNews.com - May 21 2013]

Entities: Mylan Incorporated, Appellant, Heather Bresch, Chronic Obstructive Pulmonary Disease

First reported May 20 2013 - Updated May 20 2013 - 1 reports

20 Highest-Paid Biopharma CEOs of 2012

Call it a rite of spring. Every year about this time, FiercePharma takes a look at executive compensation in the industry, and we rank the highest-paid CEOs. If you're a regular reader, you'll notice that this year's list is longer than previous editions. ... [Published FiercePharma - May 20 2013]

Entities: Daniel Vasella, Regeneron, Actavis

First reported Dec 31 2012 - Updated Dec 31 2012 - 1 reports

Famy Care receives US FDA approval for generic Nordette 28 tablets

The US Food and Drug Administration (FDA) has granted final approval for Famy Care's Abbreviated New Drug Application (ANDA) for levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg. This product is the generic version of Teva Branded Pharmaceutical ... [Published PharmaBiz - Dec 31 2012]

Entities: FDA Food & Drug Administration, Mylan Incorporated, IMS Health Inc

Quotes

Mylan CEO Heather Bresch commented, "we are pleased with the court's decision as it confirms our original belief in the strength and validity of the intellectual property protecting perforomist, as well as our combination product for the treatment of chronic obstructive pulmonary disease (copd), currently in development. we believe this decision by the court only further supports the strength of our specialty franchise."

Mylan receives favorable ruling for COPD drug patent litigation [Published Individual.com - Jun 04 2013]

Mylan CEO Heather Bresch commented, "mylan's mission is to provide the world's 7 billion people with access to high quality medicine. recently, mylan was awarded a 19% share of the arv tender conducted by the south african government and we already have begun to deliver on this commitment. building on this, today we are pleased to launch a broad and innovative arv portfolio for the private sector. we believe that mylan can set a new standard in the treatment of hiv aids in south africa by providing health care providers and those living with the disease access to high quality, affordable medicines."

Mylan introduces ARV products in South Africa for HIV/AIDS treatment [Published PharmaBiz - Feb 26 2013]

Heather Bresch CEO, Mylan said, "this collaboration builds off of our existing successful partnership for generic biologics with biocon and brings mylan a portfolio of high-value insulin analog products. this collaboration further expands and diversifies our pipeline of complex, difficult-to-manufacture products with strong future growth potential. importantly, we believe we have the opportunity to be one of the first generic entrants in developed markets into the rapidly growing diabetes area, helping to address unmet needs and reduce the economic burden to those battling the disease and to the global healthcare system."

Mylan to collaborate with Biocon to develop & commercialise three generic insulin analogue products [Published PharmaBiz - Feb 14 2013]

Heather Bresch CEO, Mylan said, "the approval and immediate launch of our levonorgestrel and ethinyl estradiol tablets usp, 0.15 mg/0.03 mg, represents an exciting advance for the women's health care franchise that mylan is establishing in partnership with famy care ltd., one of the world's largest manufacturers of oral contraceptives. presently, we have 34 oral contraceptives pending approval with the fda and expect to receive additional approvals of these products beginning in next year's first quarter."

Famy Care receives US FDA approval for generic Nordette 28 tablets [Published PharmaBiz - Dec 31 2012]

More Content

sort by: Date \| Relevance
5 Leading Women in Health Care [Published Motley Fool Discussion Boards - Jun 12 2013]
Mylan receives favorable ruling for COPD drug p... [Published Individual.com - Jun 04 2013]
Mylan: Brand/Generic Distinction Disintegration... [Published The Rose Sheet - May 22 2013]
Judge steps out of degree lawsuit [Published Charleston Gazette - May 22 2013]
Keeley recuses herself from WVU degree lawsuit [Published WCHS-TV - May 22 2013]
Keeley Recuses Herself from Heather Bresch Degr... [Published WSAZ - May 22 2013]
Federal Appellate Court rules in favor of Mylan [Published India Infoline - May 22 2013]
Professors sue WVU Board of Governors for harmi... [Published West Virginia Record - May 22 2013]
Mylan Says Appellate Court's Favorable Ruling V... [Published RTTNews.com - May 21 2013]
Federal Appellate Court Rules in Favor of Mylan... [Published Yahoo! Finance - May 21 2013]
20 Highest-Paid Biopharma CEOs of 2012 [Published FiercePharma - May 20 2013]
Mylan Management Discusses Q1 2013 Results - Ea... [Published Healthcare Sector and Stocks Analysis from Seek ... - May 03 2013]
Rajiv Malik appointed to the Board of Directors... [Published PharmaBiz - Apr 09 2013]
Strides to sell Agila to Mylan Inc. for US$ 1.6 bn [Published PharmaBiz - Feb 28 2013]
Mylan Management Discusses Q4 2012 Results - Ea... [Published Healthcare Sector and Stocks Analysis from Seek ... - Feb 28 2013]
Mylan introduces ARV products in South Africa f... [Published PharmaBiz - Feb 26 2013]
Mylan to collaborate with Biocon to develop & c... [Published PharmaBiz - Feb 14 2013]
Famy Care receives US FDA approval for generic ... [Published PharmaBiz - Dec 31 2012]
Kabler: Tax cuts, fiscal cliffs and 'Buckwild' [Published Sunday Gazette-Mail - Dec 16 2012]
W.Va. state government no stranger to no-bid co... [Published Sunday Gazette-Mail - Dec 09 2012]
Mylan Selected As One of the Leading Supplie... [Published AllAfrica.com - Nov 30 2012]
Mylan Files Expedited Motion in Relation to Pio... [Published PR Newswire - Oct 23 2012]
UN Commission sets out plan to make life-saving... [Published UNICEF - Sep 26 2012]
US FDA approves Mylan Valsartan and Hydrochloro... [Published Pharmaceutical Business Review - Sep 24 2012]
Mylan Labs selected as a leading ARV supplier t... [Published PharmaBiz - Sep 05 2012]